...
首页> 外文期刊>Plastic and reconstructive surgery >Management of Local-Regional Recurrence following Immediate Breast Reconstruction in Patients with Early Breast Cancer Treated without Postmastectomy Radiotherapy.
【24h】

Management of Local-Regional Recurrence following Immediate Breast Reconstruction in Patients with Early Breast Cancer Treated without Postmastectomy Radiotherapy.

机译:未经乳房切除术后放疗治疗的早期乳腺癌患者立即重建乳房后局部复发的管理。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: : Young age is an independent risk factor for local-regional recurrence after mastectomy in patients with T1/T2 tumors with zero or one to three positive lymph nodes. The authors evaluated the current incidence and management of local-regional recurrence after immediate breast reconstruction in patients with T1/T2 tumors and zero to three positive lymph nodes who did not receive postmastectomy radiotherapy. METHODS: : Clinical and pathologic factors were identified for 495 patients with T1/T2 tumors and zero to three positive lymph nodes who were treated with mastectomy and immediate breast reconstruction between 1997 and 2002 and did not receive primary systemic chemotherapy or postmastectomy radiation therapy. RESULTS: : Autologous tissue-based reconstruction was performed in 70 percent of patients, and 30 percent had tissue expander placement. At a median follow-up of 7.5 years, local-regional recurrence had occurred in 16 patients (3.2 percent). Independent predictors of local-regional recurrence were age 40 years or less, estrogen receptor-negative tumors, and T2 (versus T1) tumors (p < 0.05). Multimodality therapy was utilized for all 16 patients with local-regional recurrence. Nine patients (56.3 percent) who had an isolated local-regional recurrence had a 100 percent local control rate and were treated with curative intent. The 10-year overall survival rate for patients with an isolated local-regional recurrence (87.5 percent) was not significantly different from that for patients without a local-regional recurrence (90.3 percent; p = 0.234). CONCLUSIONS: : Routine use of postmastectomy radiation therapy in this heterogeneous patient population should be discouraged to allow more patients to undergo immediate breast reconstruction and ease the burden on plastic surgeons who have had to confront the problems of reconstruction in the face of perioperative radiation in an ever-increasing number of patients.
机译:背景:年轻的T1 / T2淋巴结为零或一到三个阳性淋巴结的患者,乳房切除术后局部复发是一个独立的危险因素。作者评估了T1 / T2肿瘤,零至三个阳性淋巴结未接受乳房切除术后放疗的患者,在乳房立即重建后的当前发生率和局部复发管理。方法:从1997年至2002年之间,对495例T1 / T2肿瘤,零至三个阳性淋巴结的患者进行了临床和病理学检查,这些患者接受了乳房切除术和即刻乳房再造,未接受原发性全身化疗或乳房切除术后放疗。结果:70%的患者进行了基于自体组织的重建,其中30%的患者进行了组织扩张器置入。在7.5年的中位随访中,16例患者发生了局部复发(3.2%)。局部复发的独立预测因素是年龄在40岁以下,雌激素受体阴性肿瘤和T2(相对于T1)肿瘤(p <0.05)。所有16例局部复发的患者均采用多模式疗法。 9例(56.3%)局部复发的患者局部控制率为100%,并接受了治愈性治疗。有局部复发的患者的10年总生存率(87.5%)与没有局部复发的患者的10年总生存率没有显着差异(90.3%; p = 0.234)。结论:不应鼓励在这种异类患者中常规使用乳房切除术后放疗,以使更多的患者能够立即进行乳房再造,并减轻整形外科医生的负担,因为整形外科医生不得不面对围手术期放疗中的重建问题。越来越多的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号